Key result
Severe hypertriglyceridemia is present in 0.13% of the Norwegian population and is associated with considerable co-morbidity and an imbalance of genes involved in lipid metabolism.
Cross-Sectional (n=681,990)
Yes
Severe hypertriglyceridemia has a prevalence of 0.13% in Norway and is associated with significant comorbidities including cardiovascular disease and pancreatitis, as well as altered expression of lipid metabolism genes.
Authors
No takes yet. Share an insight, caveat, or question.
Highlights the rare but high-risk clinical profile of severe hypertriglyceridemia; leaves.
Retterstøl et al. (2017) conducted a cross-sectional in Severe hypertriglyceridemia (n=681,990). Severe hypertriglyceridemia (triglycerides ≥10 mmol/L) vs. General population / Triglycerides <10 mmol/L was evaluated on Prevalence of severe hypertriglyceridemia (95% CI 0.12-0.14). Severe hypertriglyceridemia is present in 0.13% of the Norwegian population and is associated with considerable co-morbidity and an imbalance of genes involved in lipid metabolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: